Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Breakthroughs in immunotherapy for non-metastatic NSCLC

Dealing with comorbidities and toxicities in stage I-III NSCLC

Date

18 Oct 2020

Session

Breakthroughs in immunotherapy for non-metastatic NSCLC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Dirk De Ruysscher

Authors

D. De Ruysscher

Author affiliations

  • Radiation Oncology Dept (maastro Clinic), Maastro Clinic, 6229 ET - Maastricht/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.